Peptide fragments of HIV

Details Peptide fragments of HIV Peptide fragments of HIV

1994-12-09

1997-11-04

Smith, Lynette F.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

4242041, 4241881, 4241841, 530326, 530350, A61K 3804, A61K 3921, A61K 3938, C07K 100

Patent

active

056837011

ABSTRACT:
Peptides are described which have the amino acid sequence of a fragment of HIV (human immunodeficiency virus) which interacts specifically with a particular human leucocyte antigen (HLA) class I molecule, to stimulate cytotoxic T lymphocyte immunity. Such fragments can be used in a potential vaccine against AIDS (acquired immune deficiency syndrome), and for diagnostic and therapeutic purposes.

REFERENCES:
patent: 4554088 (1985-11-01), Whitehead et al.
patent: 4629783 (1986-12-01), Cosand
patent: 4772547 (1988-09-01), Heimar et al.
patent: 4808536 (1989-02-01), Chang et al.
patent: 5459238 (1995-10-01), McMichael et al.
patent: 5480967 (1996-01-01), McMichael et al.
Sternberg, FEBS Letters, vol. 218, pp. 231-237 (1987).
Mills, J. Immunol., vol. 144, pp. 1677-1683 (1990).
Bouillot et al, Nature, vol. 339, pp. 473-475 (1989).
Harlow et al, Antibodies, A Laboratory manual, Cold Spring Harbor, pp. 77, 96, 97 (1988).
Fauci et al, Annals of Internal Med., vol. 110, pp. 373-385 (1989).
Kurth, AIDS Research & Human Retroviruses, vol. 7, pp. 425-433.
Koup et al, J. of Virology, vol. 68, pp. 4650-4655 (1994).
Gotch et al, International Immunology, vol. 2, pp. 707-712 (1990).
Choppin et al, Critical Reviews in Immunology, vol. 12, pp. 1-16 (1992).
Sanchez-Madrid, PNAS US, vol. 79, pp. 7489-7493 (1982).
Ferns et al, AIDS, vol. 3, pp. 829-834 (1989).
Mathiesen, Immunology, vol. 67, pp. 453-459 (1989).
Wahren et al, J. Acquired Immune Deficiency Syndrome, vol. 4, pp. 448-456 (1989).
Parekh et al, Int. Conf. On AIDS, Jun. 4-9, 1989, p. 651.
McMichael et al, J. Exp. Med., vol. 164, pp. 1397-1406 (1986).
Gotch et al, Nature, vol. 326, pp. 881-882 (1987).
Cellular and Molecular Immunology, A.K. Abbas et al Eds., W.B. Saunders Co., Philadelphia, PA, pp. 398-401 (1991).
Immunology, Third Ed., I.M. Roitt et al Eds., Mosby, St. Louis, pp. 2.4-2.8 (1993).
Townsend et al, Cell, vol. 44, pp. 959-968 (1986), "The Epitopes of Influenza Nucleoproteins Recognized by Cytotoxic T Lymphocytes can be Defined with Short Synthetic Peptides."
Takahashi et al, Proc. Nath. Acad. Sci. USA, vol. 85, pp. 3105-3109 (1988).
Mullbacher et al, J. Immunological Methods, vol. 68, pp. 205-215 (1984).
Parish et al, J. Immunological Methods, vol. 58, pp. 225-237 (1983).
Letter of Opposition dated Nov. 1, 1996, from Peter J. Smart to European Patent Office.
Letter dated Nov. 14, 1996, from Peter J. Smart to European Patent Office.
Communication of Notice of Opposition dated Dec. 23, 1996.
Letter of Opposition dated Dec. 22, 1994, from John Raynor to European Patent Office.
Communication of Notice of Opposition dated Jan. 17, 1995.
Observations of patent proprietor relating to Notice of Opposition dated Jun. 23, 1995.
Communication from European Patent Office dated Feb. 29, 1996.
Letter from Peter J. Smart to European patent Office dated Sep. 4, 1996.
Haynes, 1993, "Scientific and Social Issues of Human . . . " Science 260:1279-1286.
Fox, 1994, "No Winners Against AIDS". Biotechnology 12:128.
Buhni, et al, 1994, "Comparative Analysis of HIV . . . " J. Cellular Biochemistry, Suppl. 18B Abstract J306.
Webster's Ninth New Collegiate Dictionary, 1990, pp. 871, 946, 1301.
Claverie, et al, 1988, "T-Immunogenic Peptides are . . . " E. J. Immunol. 18:1547-1553.
Nixon, et al, 1988, "HIV-1 Gag-Specific Cytotoxic . . . " Nature, vol. 336: 484-487.
Walker, et al. 1987, "HIV-Specific Cytotoxic T Lymphocytes . . . " Nature 328: 345-348.
Wahren, et al., 1987, "Characteristics of the Specific Cell-Mediated . . . " J. Virol. 61(6):2017-2023.
Greene, 1993, "AIDS and The Immune System" Sep. 1993. Scientific American, pp. 99-105.
Brown, 1993, "AIDS Vaccine Trials Viewed With Caution". Wash., Post Newspaper, Jun. 10, 1993.

Affiliated with

Also associated with

Rating

Peptide fragments of HIV does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide fragments of HIV, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide fragments of HIV will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1831037